Recurrent Mutations in the Basic Domain of TWIST2 Cause Ablepharon Macrostomia and Barber-Say Syndromes
- PMID: 26119818
- PMCID: PMC4572501
- DOI: 10.1016/j.ajhg.2015.05.017
Recurrent Mutations in the Basic Domain of TWIST2 Cause Ablepharon Macrostomia and Barber-Say Syndromes
Abstract
Ablepharon macrostomia syndrome (AMS) and Barber-Say syndrome (BSS) are rare congenital ectodermal dysplasias characterized by similar clinical features. To establish the genetic basis of AMS and BSS, we performed extensive clinical phenotyping, whole exome and candidate gene sequencing, and functional validations. We identified a recurrent de novo mutation in TWIST2 in seven independent AMS-affected families, as well as another recurrent de novo mutation affecting the same amino acid in ten independent BSS-affected families. Moreover, a genotype-phenotype correlation was observed, because the two syndromes differed based solely upon the nature of the substituting amino acid: a lysine at TWIST2 residue 75 resulted in AMS, whereas a glutamine or alanine yielded BSS. TWIST2 encodes a basic helix-loop-helix transcription factor that regulates the development of mesenchymal tissues. All identified mutations fell in the basic domain of TWIST2 and altered the DNA-binding pattern of Flag-TWIST2 in HeLa cells. Comparison of wild-type and mutant TWIST2 expressed in zebrafish identified abnormal developmental phenotypes and widespread transcriptome changes. Our results suggest that autosomal-dominant TWIST2 mutations cause AMS or BSS by inducing protean effects on the transcription factor's DNA binding.
Copyright © 2015 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4572501/bin/gr1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4572501/bin/gr2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4572501/bin/gr3.gif)
Similar articles
-
Multiple rhabdomyomatous mesenchymal hamartomas in a patient with mosaic Barber-Say syndrome.Pediatr Dermatol. 2024 Mar-Apr;41(2):307-310. doi: 10.1111/pde.15436. Epub 2023 Oct 10. Pediatr Dermatol. 2024. PMID: 37817291
-
Ocular adnexal phenotype and management of a patient with mosaic expression of a mutation in TWIST2.Orbit. 2022 Dec;41(6):779-782. doi: 10.1080/01676830.2021.1930066. Epub 2021 Jun 7. Orbit. 2022. PMID: 34092176
-
Clinical Description, Molecular Analysis of TWIST2 Gene, and Surgical Treatment in a Patient With Barber-Say Syndrome.Ophthalmic Plast Reconstr Surg. 2018 Mar/Apr;34(2):e61-e63. doi: 10.1097/IOP.0000000000001036. Ophthalmic Plast Reconstr Surg. 2018. PMID: 29329175
-
The focal facial dermal dysplasias: phenotypic spectrum and molecular genetic heterogeneity.J Med Genet. 2017 Sep;54(9):585-590. doi: 10.1136/jmedgenet-2017-104561. Epub 2017 Jun 29. J Med Genet. 2017. PMID: 28663233 Review.
-
Barber-Say syndrome and Ablepharon-Macrostomia syndrome: An overview.Am J Med Genet A. 2016 Aug;170(8):1989-2001. doi: 10.1002/ajmg.a.37757. Epub 2016 May 19. Am J Med Genet A. 2016. PMID: 27196381 Review.
Cited by
-
Transition from natal downs to juvenile feathers: conserved regulatory switches in Neoaves.Res Sq [Preprint]. 2023 Oct 3:rs.3.rs-3382427. doi: 10.21203/rs.3.rs-3382427/v1. Res Sq. 2023. Update in: Nat Commun. 2024 May 16;15(1):4174. doi: 10.1038/s41467-024-48303-3. PMID: 37886492 Free PMC article. Updated. Preprint.
-
Mechanisms of Regulation of the CHRDL1 Gene by the TWIST2 and ADD1/SREBP1c Transcription Factors.Genes (Basel). 2023 Aug 30;14(9):1733. doi: 10.3390/genes14091733. Genes (Basel). 2023. PMID: 37761873 Free PMC article.
-
Novel genetic associations with five aesthetic facial traits: A genome-wide association study in the Chinese population.Front Genet. 2022 Aug 12;13:967684. doi: 10.3389/fgene.2022.967684. eCollection 2022. Front Genet. 2022. PMID: 36035146 Free PMC article.
-
Single Nucleotide Polymorphism of TWIST2 May Be a Modifier for the Association between High-Density Lipoprotein Cholesterol and Blood Lead (Pb) Level.Int J Environ Res Public Health. 2022 Jan 26;19(3):1352. doi: 10.3390/ijerph19031352. Int J Environ Res Public Health. 2022. PMID: 35162374 Free PMC article.
-
Clinical and Molecular Delineation of Cutis Laxa Syndromes: Paradigms for Homeostasis.Adv Exp Med Biol. 2021;1348:273-309. doi: 10.1007/978-3-030-80614-9_13. Adv Exp Med Biol. 2021. PMID: 34807425 Review.
References
-
- Cruz A.A.V., Guimarães F.C., Obeid H.N., Ferraz V.E.F., Noce T.R., Martinez F.E. Congenital shortening of the anterior lamella of all eyelids: the so-called ablepharon macrostomia syndrome. Ophthal. Plast. Reconstr. Surg. 1995;11:284–287. - PubMed
-
- Cruz A.A., Souza C.A., Ferraz V.E., Monteiro C.A., Martins F.A. Familial occurrence of ablepharon macrostomia syndrome: eyelid structure and surgical considerations. Arch. Ophthalmol. 2000;118:428–430. - PubMed
-
- Amor D.J., Savarirayan R. Intermediate form of ablepharon-macrostomia syndrome with CNS abnormalities. Am. J. Med. Genet. 2001;103:252–254. - PubMed
-
- Barber N., Say B., Bell R.F., Merveille O.C. Macrostomia, ectropion, atrophic skin, hypertrichosis and growth retardation. Syndr. Ident. 1982;8:6–9.
-
- Brancati F., Mingarelli R., Sarkozy A., Dallapiccola B. Ablepharon-macrostomia syndrome in a 46-year-old woman. Am. J. Med. Genet. A. 2004;127A:96–98. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases